Skip to main content

MoneyWorks4Me

Wockhardt informs about press release

11 Dec 2023 Evaluate
Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873’, which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..